Literature DB >> 12767064

Upregulation of MMPs by soluble E-cadherin in human lung tumor cells.

Béatrice Nawrocki-Raby1, Christine Gilles, Myriam Polette, Erik Bruyneel, Jean-Yves Laronze, Noël Bonnet, Jean-Michel Foidart, Marc Mareel, Philippe Birembaut.   

Abstract

Loss of E-cadherin/catenin mediated cell-cell adhesion and overexpression of matrix metalloproteinases (MMPs) are largely involved in tumor invasion. It has been recently shown that high levels of a soluble 80 kDa fragment of E-cadherin, resulting from a cleavage by MMPs, are found in serum and in urine from cancer patients. Additionally, this soluble E-cadherin (sE-CAD) promotes cell invasion into chick heart and into collagen type I gels. The aim of our study was to examine the mechanism of sE-CAD-induced cell invasion. Since MMPs play a crucial role in invasion, we looked for induction of MMPs by sE-CAD in noninvasive human lung tumor cells 16HBE. An induction of MMP-2, MMP-9 and MT1-MMP expression was observed both at the mRNA and at the protein level in the presence of sE-CAD (in conditioned medium form or in E-cadherin HAV peptide form). No induction of MMP-1, -3 and -7 or variation of the levels of their inhibitors, TIMP-1 and TIMP-2, were detected. The biologic relevance of the sE-CAD-induced MMP upregulation was tested by demonstrating that sE-CAD promotes in vitro cell invasion in a modified Boyden chamber assay. These data provide new insight into mechanisms of tumor invasion by ectodomain shedding of the cell-cell adhesion molecule E-cadherin. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767064     DOI: 10.1002/ijc.11168

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  42 in total

Review 1.  Matrix metalloproteinase control of capillary morphogenesis.

Authors:  Cyrus M Ghajar; Steven C George; Andrew J Putnam
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

2.  Cadherin-6B proteolytic N-terminal fragments promote chick cranial neural crest cell delamination by regulating extracellular matrix degradation.

Authors:  Andrew T Schiffmacher; Ashrifia Adomako-Ankomah; Vivien Xie; Lisa A Taneyhill
Journal:  Dev Biol       Date:  2018-06-27       Impact factor: 3.582

3.  The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation.

Authors:  Abdo J Najy; Kathleen C Day; Mark L Day
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

Review 4.  Nuclear signaling from cadherin adhesion complexes.

Authors:  Pierre D McCrea; Meghan T Maher; Cara J Gottardi
Journal:  Curr Top Dev Biol       Date:  2015-02-12       Impact factor: 4.897

Review 5.  E-cadherin's dark side: possible role in tumor progression.

Authors:  Fausto J Rodriguez; Laura J Lewis-Tuffin; Panos Z Anastasiadis
Journal:  Biochim Biophys Acta       Date:  2012-03-13

Review 6.  Influence of the microenvironment on cell fate determination and migration.

Authors:  Alexander B Bloom; Muhammad H Zaman
Journal:  Physiol Genomics       Date:  2014-03-11       Impact factor: 3.107

Review 7.  Soluble cadherins as cancer biomarkers.

Authors:  Olivier De Wever; Lara Derycke; An Hendrix; Gert De Meerleer; François Godeau; Herman Depypere; Marc Bracke
Journal:  Clin Exp Metastasis       Date:  2007-10-19       Impact factor: 5.150

8.  ADAM-10-mediated N-cadherin cleavage is protein kinase C-alpha dependent and promotes glioblastoma cell migration.

Authors:  Zachary A Kohutek; Charles G diPierro; Gerard T Redpath; Isa M Hussaini
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

9.  Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling.

Authors:  S M Brouxhon; S Kyrkanides; X Teng; M Athar; S Ghazizadeh; M Simon; M K O'Banion; L Ma
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

10.  Soluble E-cadherin: an early marker of severity in acute pancreatitis.

Authors:  A Sewpaul; J J French; T K Khoo; M Kernohan; J A Kirby; R M Charnley
Journal:  HPB Surg       Date:  2009-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.